A detailed history of Jane Street Group, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 13,459 shares of SRDX stock, worth $512,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,459
Previous 21,211 36.55%
Holding current value
$512,653
Previous $891,000 41.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$38.47 - $42.24 $298,219 - $327,444
-7,752 Reduced 36.55%
13,459 $521,000
Q2 2024

Aug 14, 2024

BUY
$25.39 - $42.1 $538,547 - $892,983
21,211 New
21,211 $891,000
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $1.55 Million - $3.48 Million
90,401 New
90,401 $2.06 Million
Q3 2021

Nov 16, 2021

SELL
$52.8 - $60.32 $198,950 - $227,285
-3,768 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $193,260 - $222,877
3,768 New
3,768 $204,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.